Hualan Vaccine: The net profit in 2025 is 183 million yuan, a year-on-year decrease of 10.99%.

Huaz Lan Vaccine Announcement: in 2025, the operating income was 1.203 billion yuan, a year-on-year increase of 6.62%. Net profit was 183 million yuan, a year-on-year decrease of 10.99%. The profit distribution plan approved by the board of directors is as follows: based on a total of 595 million yuan, a cash dividend of 8 yuan will be distributed to every 10 shares held by all shareholders, no bonus shares will be given, and no additional shares will be added to all shareholders' capital reserve funds for every 10 shares held.